Glenn A. Oclassen

Who is Glenn A. Oclassen?

In 1985 Mr. Oclassen founded Oclassen Pharmaceuticals, Inc.,

a dermatologic drug development and marketing company. He served as a director

from the company's inception, was President and CEO from 1985 until 1991,

and became Chairman of the Board of Directors in January 1991. He served

in this role until Watson Pharmaceuticals acquired the company in February

1997. He was also a founder and Chairman of the Board of NextDerm Inc.,

a venture that was acquired in 1999 by Procyte Corp., and is a member of

the board of directors of Neosil Corporation.

From 1984 to 1985 Mr. Oclassen served as President and Chief

Operating Officer of Pharmaquest Corporation, a pharmaceutical development

consulting company. From 1982 to 1984, he was a partner in the Peachtree

Creek Consulting Group, a firm providing marketing consulting services

to health care and consumer products companies. In 1977, Mr. Oclassen founded

the Neutrogena Dermatologics division of Neutrogena Corp. and served as

President until 1982. He was employed by Allergan Pharmaceuticals from

1971 until 1977 where he was concurrently Director of Marketing for OTC

ophthalmic products, and General Manager of the Dermatology Division.

Mr. Oclassen previously held marketing and sales positions

with Westwood Pharmaceuticals, which was founded by his father Charles

A. Oclassen, and with Wm. H. Rorer Pharmaceuticals. He received a B.S.

in zoology from San Diego State University in 1965. Mr. Oclassen is a member

of the Cutaneous Therapy Society and the North American Clinical Dermatology

Society.